Literature DB >> 21828262

Regulation of estrogen sulfotransferase expression by confluence of MCF10A breast epithelial cells: role of the aryl hydrocarbon receptor.

Jiaqi Fu1, Hailin Fang, Michelle Paulsen, Mats Ljungman, Thomas A Kocarek, Melissa Runge-Morris.   

Abstract

Estrogen sulfotransferase (SULT1E1) catalyzes the sulfonation of estrogens, which limits estrogen mitogenicity. We recently reported that SULT1E1 expression is low in preconfluent MCF10A human breast epithelial cells but increases when the cells become confluent. Pulse-chase labeling experiments with 5-bromouridine demonstrated that the confluence-mediated increase in SULT1E1 expression was due to increased mRNA synthesis. Because aryl hydrocarbon receptor (AhR) activation has been shown to suppress SULT1E1 expression and loss of cell-cell contact has been shown to activate the AhR in other cell types, we tested whether the confluence-associated changes in SULT1E1 expression were mediated by the AhR. Relative to confluent MCF10A cells, preconfluent cells had higher levels of CYP1A1 mRNA and greater activation of an AhR-responsive luciferase reporter, demonstrating that the AhR was active in the preconfluent cells. AhR and aryl hydrocarbon receptor nuclear translocator mRNA and protein levels were also higher in preconfluent than in confluent cultures. Treatment of preconfluent cells with the AhR antagonist, 3'-methoxy-4'-nitroflavone (MNF), or AhR knockdown significantly increased SULT1E1 expression. MCF10A cells stably transfected with a luciferase reporter containing ∼7 kilobases of the SULT1E1 5'-flanking region showed both MNF- and confluence-inducible luciferase expression. Preconfluent cells transiently transfected with the reporter showed both MNF treatment- and AhR knockdown-mediated luciferase induction, but mutation of a computationally predicted dioxin response element (DRE) at nucleotide (nt) -3476 did not attenuate these effects. These results demonstrate that SULT1E1 expression in MCF10A cells is transcriptionally regulated by confluence through a suppressive action of the AhR, which is not mediated through a DRE at nt -3476.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21828262      PMCID: PMC3199978          DOI: 10.1124/jpet.111.185173

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  40 in total

Review 1.  Sulfotransferases in the bioactivation of xenobiotics.

Authors:  H Glatt
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

2.  Identification of a novel dioxin-inducible cytochrome P450.

Authors:  Steven P Rivera; Sirkku T Saarikoski; Oliver Hankinson
Journal:  Mol Pharmacol       Date:  2002-02       Impact factor: 4.436

3.  Gene expression: Oestrogen receptor hijacked.

Authors:  Jan J Brosens; Malcolm G Parker
Journal:  Nature       Date:  2003-05-29       Impact factor: 49.962

4.  Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation.

Authors:  Y M Qian; X J Sun; M H Tong; X P Li; J Richa; W C Song
Journal:  Endocrinology       Date:  2001-12       Impact factor: 4.736

5.  The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.

Authors:  C M Klinge; K Kaur; H I Swanson
Journal:  Arch Biochem Biophys       Date:  2000-01-01       Impact factor: 4.013

6.  Transient expression of CYP1A1 in rat epithelial cells cultured in suspension.

Authors:  S A Monk; M S Denison; R H Rice
Journal:  Arch Biochem Biophys       Date:  2001-09-01       Impact factor: 4.013

7.  Analysis of the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human ovarian carcinoma BG-1 cells.

Authors:  Jane M Rogers; Michael S Denison
Journal:  Mol Pharmacol       Date:  2002-06       Impact factor: 4.436

8.  The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.

Authors:  Mark Wormke; Matthew Stoner; Bradley Saville; Kelcey Walker; Maen Abdelrahim; Robert Burghardt; Stephen Safe
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

9.  Regulation of Cyp1a1 induction by dioxin as a function of cell cycle phase.

Authors:  R P Santini; S Myrand; C Elferink; J J Reiners
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

10.  Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.

Authors:  Jiaqi Fu; Amy M Weise; Josie L Falany; Charles N Falany; Bryan J Thibodeau; Fred R Miller; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Breast Cancer Res Treat       Date:  2009-03-24       Impact factor: 4.872

View more
  8 in total

1.  Regulation of Cytosolic Sulfotransferases in Models of Human Hepatocyte Development.

Authors:  Sarah Dubaisi; Kathleen G Barrett; Hailin Fang; Jorge Guzman-Lepe; Alejandro Soto-Gutierrez; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2018-06-01       Impact factor: 3.922

2.  Resveratrol and its methoxy derivatives modulate the expression of estrogen metabolism enzymes in breast epithelial cells by AhR down-regulation.

Authors:  Barbara Licznerska; Hanna Szaefer; Marcin Wierzchowski; Hanna Sobierajska; Wanda Baer-Dubowska
Journal:  Mol Cell Biochem       Date:  2016-11-16       Impact factor: 3.396

3.  SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites.

Authors:  L P Madhubhani P Hemachandra; Hitisha Patel; R Esala P Chandrasena; Jaewoo Choi; Sujeewa C Piyankarage; Shuai Wang; Yijin Wang; Emily N Thayer; Robert A Scism; Bradley T Michalsen; Rui Xiong; Marton I Siklos; Judy L Bolton; Gregory R J Thatcher
Journal:  Cancer Prev Res (Phila)       Date:  2014-03-05

Review 4.  Phase two steroid metabolism and its roles in breast and prostate cancer patients.

Authors:  Keely M McNamara; Yasuhiro Nakamura; Yasuhiro Miki; Hironobu Sasano
Journal:  Front Endocrinol (Lausanne)       Date:  2013-09-04       Impact factor: 5.555

5.  Derivation of a no-significant-risk-level for tetrabromobisphenol A based on a threshold non-mutagenic cancer mode of action.

Authors:  Alison M Pecquet; Jeanelle M Martinez; Melissa Vincent; Neeraja Erraguntla; Michael Dourson
Journal:  J Appl Toxicol       Date:  2018-02-13       Impact factor: 3.446

6.  Tristetraprolin mediates radiation-induced TNF-α production in lung macrophages.

Authors:  Dipankar Ray; Shirish Shukla; Uday Sankar Allam; Abigail Helman; Susmita Gurjar Ramanand; Linda Tran; Michael Bassetti; Pranathi Meda Krishnamurthy; Matthew Rumschlag; Michelle Paulsen; Lei Sun; Thomas P Shanley; Mats Ljungman; Mukesh K Nyati; Ming Zhang; Theodore S Lawrence
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

7.  Hop (Humulus lupulus L.) Extract and 6-Prenylnaringenin Induce P450 1A1 Catalyzed Estrogen 2-Hydroxylation.

Authors:  Shuai Wang; Tareisha L Dunlap; Caitlin E Howell; Obinna C Mbachu; Emily A Rue; Rasika Phansalkar; Shao-Nong Chen; Guido F Pauli; Birgit M Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2016-06-22       Impact factor: 3.739

8.  Breast cancer pathogenesis is linked to the intra-tumoral estrogen sulfotransferase (hSULT1E1) expressions regulated by cellular redox dependent Nrf-2/NFκβ interplay.

Authors:  Aarifa Nazmeen; Guangping Chen; Tamal Kanti Ghosh; Smarajit Maiti
Journal:  Cancer Cell Int       Date:  2020-03-04       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.